PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia
Xi Xu(Brigham and Women's Hospital), Linjia Jiang(Sun Yat-sen University), Jacqelyn Nemechek(Children's Mercy Hospital), Meng Zhao(Sun Yat-sen University), Minyi Zhao(Northeast Agricultural University), Weiwei Ma(Capital University), Siyu Xie(China Agricultural University), Xue Han(Shanxi Medical University), Yanhui Yu(Harbin Medical University), Chong He(Wuhan Textile University), Wen‐Wen Zhang(Fujian Medical University), Wen Zheng(Unknown), Tao Fang(Children's Mercy Hospital), John M. Perry(Children's Mercy Hospital), Yuhua Qu(Nanfang Hospital), Qifa Liu(Children's Mercy Hospital), Li Xuan(Commercial Aircraft Corporation of China (China)), Jian Wang(Sun Yat-sen University)
Cited by 34
Related Papers
Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
|Journal of Clinical Investigation|2015|1.4k
Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion
|Cell Research|2018|263
Elevated frequencies of CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>lo</sup> regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia
|International Journal of Cancer|2010|202
Cooperation between both Wnt/β-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion
|Genes & Development|2011|197
The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations
|Aging and Disease|2020|128